Delivery Order SPE2DB20D3303-SPE2DB24FZ8D3

Award Date 5/23/24
Potential Completion Date 5/24/24
Potential Value $14K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,536.07 firm fixed-price delivery order is for the supply of SPIRIVA RESPIMAT 2.5 MCG INH 4GM, a prescription respiratory medication. The contract has an ultimate completion date of January 18, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,486.09 firm fixed-price delivery order contract is for the supply of SPIRIVA RESPIMAT 2.5 MCG INH 4GM, a pharmaceutical product. The contract has a period of performance through September 9, 2024 and was awarded on September 6, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,000.75 firm fixed-price delivery order is for the supply of SPIRIVA RESPIMAT 2.5 MCG INH 4GM, a respiratory medication. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of SPIRIVA RESPIMAT 2.5 MCG INH 4GM. The contract has a ceiling value of $1,470.49 and is a Firm Fixed Price Delivery Order that runs through February 2025. This award is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which provides a...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,290.49, is a delivery order for SPIRIVA RESPIMAT 2.5 MCG INH 4GM, a respiratory medication. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by Amerisourcebergen with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,519.03 firm fixed-price delivery order is for the supply of SPIRIVA RESPIMAT 2.5 MCG INH 4GM, a respiratory medication. The contract has a completion date of November 25, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,944.43, is for the delivery of SPIRIVA RESPIMAT 2.5 MCG INH 4GM, a respiratory medication. The award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical. This IDC serves as a primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,408.98 firm fixed-price delivery order is for the supply of SPIRIVA RESPIMAT 2.5 MCG INH 4GM, a respiratory medication. The contract has an ultimate completion date of June 3, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of SPIRIVA RESPIMAT 2.5 MCG INH 4GM medication. The $1,434.79 firm fixed-price delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,736.58 firm fixed-price delivery order is for the supply of SPIRIVA RESPIMAT 2.5 MCG INH 4GM, a respiratory medication. The contract has an ultimate completion date of February 3, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
  • SPE2DB20D3303
    Indefinite Delivery Contract
  • SPE2DB20D3303-SPE2DB24FZ8D3
    Delivery Order

This federal contract award, valued at $14,490.01, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, covers the procurement of SPIRIVA RESPIMAT 2.5 MCG INH 4GM, a pharmaceutical product. The IDC is valued at $999,999,999 and runs through November 2026, serving as a primary vehicle for the DLA to acquire a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award was not designated with a set-aside requirement, indicating open competition. AmerisourceBergen, as the prime contractor, is responsible for delivering the specified pharmaceutical product to the government.

Generated 5/16/25, 12:34 PM